JT
JM Thornton
info
Please Note
<p>This page displays the records of the person named above and is not linked to a unique person identifier. This record may need to be merged to a profile.</p>
1 records found
1
Our aim is to prioritize human missense mutations by their probability of being disease causing. Such a computational method could be used to obtain a reduced set of mutations with a relatively large fraction of disease related mutations, thereby aiding in the search for this type of mutation within a large mutation set.
Whereas a range of methods is available for this purpose, only few employ the availability of the 1000G data to obtain a set of neutral mutations. The novelty of our approach is the use of separate classifiers that were trained on a subset of mutations from one amino acid to any other amino acid. The combined performance of these classifiers show an improved performance compared to the often used prediction method PolyPhen2. ...
Whereas a range of methods is available for this purpose, only few employ the availability of the 1000G data to obtain a set of neutral mutations. The novelty of our approach is the use of separate classifiers that were trained on a subset of mutations from one amino acid to any other amino acid. The combined performance of these classifiers show an improved performance compared to the often used prediction method PolyPhen2. ...
Our aim is to prioritize human missense mutations by their probability of being disease causing. Such a computational method could be used to obtain a reduced set of mutations with a relatively large fraction of disease related mutations, thereby aiding in the search for this type of mutation within a large mutation set.
Whereas a range of methods is available for this purpose, only few employ the availability of the 1000G data to obtain a set of neutral mutations. The novelty of our approach is the use of separate classifiers that were trained on a subset of mutations from one amino acid to any other amino acid. The combined performance of these classifiers show an improved performance compared to the often used prediction method PolyPhen2.
Whereas a range of methods is available for this purpose, only few employ the availability of the 1000G data to obtain a set of neutral mutations. The novelty of our approach is the use of separate classifiers that were trained on a subset of mutations from one amino acid to any other amino acid. The combined performance of these classifiers show an improved performance compared to the often used prediction method PolyPhen2.